tag:blogger.com,1999:blog-7857054149675424609.post5834422864694808883..comments2024-02-24T08:58:08.581+00:00Comments on RNAi Therapeutics: ISIS Wasting No Time to Find Out Clinical Utility of Spinal Muscular Atrophy DrugDirk Hausseckerhttp://www.blogger.com/profile/18320439857875629714noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-7857054149675424609.post-71252535036442247612014-05-01T13:47:54.185+00:002014-05-01T13:47:54.185+00:00"Nevertheless, since ISIS-SMNRx seems safe an..."Nevertheless, since ISIS-SMNRx seems safe and was shown to successfully address the disease at its root in babies and children- which also means that it could synergize with other future treatments- regulators should consider the full potential of this drug, present and future, when making a decision as to its approvability in 2016/2017."<br /><br />Was pleased to see you emphasize Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-75270164843830462322014-05-01T12:42:20.093+00:002014-05-01T12:42:20.093+00:00Isis also provided updates for ISIS-SMN Rx at the ...Isis also provided updates for ISIS-SMN Rx at the 2014 annual meeting of the American Academy of Neurology.Anonymousnoreply@blogger.com